Please enable Javascript
Dhaval Mehta, MD
Dhaval Mehta, MD
Articles by Dhaval Mehta, MD
Emerging Radiopharmaceuticals and PARP Inhibitors in Prostate Cancer Treatment
Leonard J. Appleman, MD, PhD
RLT
|
October 29, 2024
The final segment of this roundtable series discusses radiopharmaceuticals and PARP inhibitors.
View More
Insights From ARANOTE and PEACE 3 Trials: Optimizing Prostate Cancer Treatment
Leonard J. Appleman, MD, PhD
mCSPC
|
October 29, 2024
Part five of this roundtable series covers data and insights from the ARANOTE and PEACE 3 trials.
View More
Triplet Therapy vs. ADT: Choosing the Right Approach for Metastatic Prostate Cancer
Leonard J. Appleman, MD, PhD
mCSPC
|
October 25, 2024
Part four of a PCa roundtable series focuses on the effectiveness of ADT with triplet therapy.
View More
Prognostic Factors in Prostate Cancer: Gleason Scores, PSA Levels, and Genomic Testing
Leonard J. Appleman, MD, PhD
Prostate Cancer Diagnostics
|
October 24, 2024
Part three of this prostate cancer roundtable covers prognostic factors such as Gleason scores and genomic assays.
View More
Are Bone Scans Obsolete? Evolving Imaging Techniques in Prostate Cancer
Leonard J. Appleman, MD, PhD
Prostate Cancer Diagnostics
|
October 24, 2024
Part two of this roundtable features a discussion on the role of bone scans compared to the newer PSMA PET scans.
View More
The Role of PSMA PET in Advanced Prostate Cancer Treatment Decisions
Leonard J. Appleman, MD, PhD
Prostate Cancer Diagnostics
|
October 24, 2024
The first part of this roundtable focuses on the impact of recent research on clinical practice.
View More